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12 Abstract: 
13 Mammalian cells repair double-strand DNA breaks (DSB) by a range of different 
14 pathways following DSB induction by the engineered clustered regularly interspaced 
15 short palindromic repeats (CRISPR)-associated protein Cas9. While CRISPR-Cas9 
16 thus enables predesigned modifications of the genome, applications of CRISPR-
17 Cas9-mediated genome-editing are frequently hampered by the unpredictable and 
18 varying pathways for DSB repair in mammalian cells. Here we present a strategy of 
19 fusing Cas9 to recombinant proteins for fine-tuning of the DSB repair preferences in 
20 mammalian cells. By fusing Streptococcus Pyogenes Cas9 (SpCas9) to the 
21 recombinant protein A (Rec A, NP_ 417179.1) from E. coli, we create a recombinant 
22 Cas9 protein (rSpCas9) which enhances the generation of indel mutations at DSB 
23 sites in mammalian cells, increases the frequency of DSB repair by homology-
24 directed single-strand annealing (SSA), and represses homology-directed gene 
25 conversion by approximately 33%. Our study thus proves for the first time that fusing 
26 SpCas9 to recombinant proteins can influence the balance between DSB repair 
27 pathways in mammalian cells. This approach may form the basis for further 
28 investigations of the applications of recombinant Cas9 proteins to fine-tuning DSB 
29 repair pathways in eukaryotic cells. 
30 
31 Keywords: 
32 CRISPR; SpCas9; Rec A" , SpCas9(1.1 ); DSB; SSA 
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2 1. lntroduction 
3 The bacterial clustered regularly interspaced short palindromic repeats (GRISPR)-
4 associated protein 9 (Gas9) has revolutionized genome-editing in various cells and 
5 organisms (Gong et al., 2013; Jinek et al., 2012; Jinek et al., 2013; Mali et al., 2013). 
6 The most widely used Gas9 is from Streptococcus pyogenes (SpGas9) and can be 
7 programmed by a single small guide RNA (gRNA) to target any desired genomic 
8 locus that is followed by a protospacer-adjacent motif (PAM, 5'NGG). The Gas9 
9 protein then catalyzes the formation of a double-strand DNA break (DSB) 3 
10 nucleotides upstream of the PAM (Gong et al., 2013; Jinek et al., 2012). ln 
11 mammalian cells, unrepaired DSBs are frequently lethal, and cells have evolved 
12 several different mechanisms to repair DSBs (Huertas, 201 0). These include simply 
13 rejoining the two DNA fragments with little or no further processing (non-homologous 
14 end joining, NHEJ) (Lieber, 2008) and a set of pathways using homologaus 
15 sequences for DSB repair, collectively known as homologaus recombination (HR) 
16 (Krogh and Symington, 2004). Single-strand annealing (SSA) is a DSB repair 
17 pathway that anneals and ligates two homologaus regions flanking the DSB site 
18 resulting in a precise deletion of the intervening sequences (Huertas, 201 0; Krogh 
19 and Symington, 2004). lt has been discovered that microhomology-mediated end 
20 joining (MMEJ), which shares molecular signatures with both NHEJ and SSA 
21 (McVey and Lee, 2008), is also frequently used along with NHEJ/SSA for DSB repair 
22 by mammalian cells. These error-prone repair mechanisms have greatly facilitated 
23 the use of Gas9 for gene knockout applications as they commonly result in non-
24 sense mutations. However, a challenge in GRISPR-Gas9 based genome editing is 
25 the Iack of tools for controlling the choice of DSB repair pathways in cells. This has 
26 great increased the workload necessary to generate genetically modified cells with 
27 desired mutations due to the necessity for extensive screening and analysis. 
28 
29 lt has previously been shown that fusion of a catalytically inactive Gas9 (dGas9) to 
30 functional proteins or catalytic domains can greatly broaden the GRISPR-Gas9-
31 based genome and epigenome editing toolbox. Prominent examples include the 
32 fusion of dGas9 to the G terminus of the transcriptional activation domain VP64 
33 (dGas9-VP64) for gene activation (Gilbert et al., 2013) or the Krüppel associated box 
2 
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1 (KRAB) transcriptional repressor domain (dCas9-KRAB) for gene inhibition (Qi et al., 
2 2013). lt has also previously been shown that catalytically active Cas9 remains 
3 bound to both ends of the cleaved DNA following generation of a DSB (Sternberg et 
4 al., 2014). We therefore hypothesized that a similar fusion approach can be used to 
s influence the preferences of DSB repair pathways by fusing a catalytically active 
6 wild-type Cas9 protein to the N terminus of a protein or domain of interest to yield 
7 multifunctional recombinant fusion proteins. Here we show that this strategy can be 
8 used to generate fusion proteins which retain the Cas9 endonuclease activity while 
9 simultaneously influencing the balance of DSB repair pathways in mammalian cells. 
10 
11 
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2 2. Materials and Methods 
3 2.1. CRISPR gRNA design 
4 CRISPR gRNAs were designed using the online prediction tool 
5 (http://crispr.mit.edu/). EMX1 and HEK293 site 2 gRNA target sites were selected 
6 from a previous validated study (Tsai et al., 2015). All gRNA target sequences are 
7 listed in Supplementary Table 1. 
8 
9 2.2. DNA oligonucleotide synthesis and Sanger sequencing 
10 All DNA oligonucleotides in this study were synthesized from Sigma Aldrich 
11 (Denmark, Europe). Sanger sequencing was conducted using the Mix2seq kit from 
12 Eurotin Genomics (Germany). 
13 
14 2.3. Generation of fusion eSpCas9 expression vectors, gRNA expression 
15 vectors, and C-Check vectors 
16 The SpCas9 (Addgene plasmid # 48139) and eSpCas9(1.1) (Addgene plasmid # 
17 71814) plasmids were a gift from Feng Zhang. The E.Coli RecA coding region 
18 (NP_ 417179.1) was human codon optimized and synthesized by lnvitrogen GeneArt 
19 Gene Synthesis (ThermoFisher Scientific). All fusion plasmids (SpCas9-RecA and 
20 eSpCas9-RecA) were validated by restriction enzyme digestion and Sanger 
21 sequencing to ensure correct fusion with no unintended mutations introduced by 
22 PCR and will be available through Addgene 
23 (https://www.addgene.org/Yonglun Luo/). Addgene plasmid 10: 87263 and 87264. 
24 
25 To generate the gRNA expression vectors, complementary gRNA oligonucleotides 
26 were annealed in 1 X NEB buffer 2, cloned into a single gRNA expression plasmid 
27 with a human-U6 promoter, and subsequently validated by Sanger sequencing. To 
28 generate the C-Check reporter vectors, complementary DNA oligonucleotides that 
29 contain a gRNA target site were annealed and cloned into the C-Check vector 
30 (Addgene plasmid #66817) by golden gate assembly, following our protocol 
31 described previously (Zhou et al., 2016). All C-Check vectors were validated by 
32 Sanger sequencing 
33 
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1 2.4. Cell culture 
2 HEK293T, Hela and U20S cells (ATCC) were cultivated in Dulbecco's modified 
3 Eagle's medium (DMEM) (LONZA) supplied with 10% FBS (Gibco), 1% penicillin-
4 Streptomycin (Sigma), 1% GlutaMAX (Gibco) in a 3JCC incubator with 5% C02 and 
5 maximum humidity. The TLR cell line was a gift from Chu et al. 2015. At 
6 approximately 80% confluence, cells were detached by 0.05% Trypsin-EDT A and 
7 passaged at a ratio of 1 :8. 
8 
9 2.5. Transfeetion 
10 ln this study, all transfections were performed using the X-tremeGENE9 DNA 
11 transfection reagent (Rache) following the manufacturer's instructions. Briefly, cells 
12 were seeded into 24-well plates one day before transfection with a cell density of 
13 5X1 04 cells perweil for HEK293T cells and 1 X1 04 cells perweil for He La and U20S 
14 cells. Foreach transfection, a total amount of 250 ng of plasmids was used (3:1 ratio 
15 of Cas9 to gRNA). A pUC19 plasmid was used for transfection of control groups in 
16 the same amount as the combined plasmids of non-control groups. 
17 
18 2.6. Flow cytometry (FCM) 
19 Flow cytometry analysiswas performed using a four-laser FACSAria 111 cell sorterat 
20 the FACS CORE facility of Aarhus University. At least 10,000 events were analyzed 
21 per biological replicate (independent transfection). 
22 
23 2.7. C-Check analysis 
24 For each transfection, Cas9, gRNA and C-Check plasmid was used in a 3:1 :4 ratio. 
25 48 hours after transfection, cells were harvested using 0.025% trypsin-PBS-EDTA 
26 (phenol red free) and washed twice with PBS-5%FBS, fixed with 4% Formaldehyde-
27 PBS solution for 10 min at R.T and washed with PBS twice before analysis. The 
28 percentage of GFP+ cells out of the AsRED+ cells was quantified by FCM. 
29 
30 2.8. TLR analysis 
31 24 hours before transfection, 50,000 TLR cells were seeded per weil in a 24-well 
32 plate. Foreach transfection, Cas9 (90 ng), gRNA (30 ng) and donor plasmid (30 ng) 
33 were used. 
5 
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1 
2 For the TLR-Iike plasmid based reporter system, 50,000 HEK293T cells were 
3 seeded perweil in a 24-well plate 24 hours before transfection. Foreach transfection, 
4 the following plasmids were used: Cas9 (90 ng), gRNA (30 ng), donor plasmid (70 
5 ng) and TLR-Iike plasmid (1 0 ng). 
6 
7 Transfeetions were performed using the X-tremeGENE9 DNA transfection reagent 
8 (Rache) according to the manufacturer's instructions. 24 hours after transfection, 
9 fresh cell culture medium was added to the cells, and transfected cells were 
10 harvested for FCM analysis 72 hours after transfection. At least 10,000 events were 
11 analyzed per biological replicate (independent transfection). 
12 
13 2.9 Detection of gene deletion mediated by pairs of gRNAs. 
14 To evaluate gene deletion facilitated by pairs of gRNAs, HEK293T cells were 
15 transfected with Cas9 (SpCas9 or rSpCas9) and a pair of gRNA expression plasmids. 
16 48 hours after transfection, genomic DNA was purified from the transfected cells 
17 (DNeasy Blood & Tissue Kit, Cat No. 69504) and 50 ng genomic DNA was used for 
18 PCR using primers flanking the deleted regions. All PCR primers are listed in 
19 supplementary table 1. Quantification of deletion (KO) and wildtype (wt) band 
20 intensity was performed with Image J. 
21 
22 2.1 0. Western blot analysis 
23 HEK293T cells were transfected with Cas9 expression plasmids in a 6-well plate. 
24 Two days after transfection, cells were harvested by trypsinization and washed with 
25 PBS three times. The cells were then resuspended in Iysis buffer (1 OmM Tris-HCI 
26 (pH 7.4)), 137mM NaCI, 10% Glycerol, 1% NP40 and protease inhibitors) by 
27 vortexing. Following resuspension, the cells were placed on dry ice for 3 min, 
28 transferred to 3JCC, and vortexed. The freeze-thaw cycles were repeated 3 times 
29 and the lysates were placed on ice for 30 min. After centrifugation at 10,000 rpm at 
30 6°C for 1 Omin, the supernatant was transferred into a new tube and protein 
31 concentrations were determined with Qubit Fluorometer (ThermoFisher 
32 Scientific). 21Jg lysate was boiled at 100 oc for 5 min and loaded on gradient SDS-
33 PAGEgels (4-15%). Blots were probed with anti-FLAG M2 (F1804, Sigma) and anti-
6 
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1 beta-tubulin (ab6046, abcam) antibodies. Blots were developed with secondary goat 
2 anti-rabbit lgG HRP (sc-2004, Santa Cruz Biotechnology) or anti-mause lgG HRP 
3 (sc-2005, Santa Cruz Biotechnology) and bands visualized using the Immobilen 
4 Western Chemiluminescent HRP Substrate (WBKLS01 00). Images were taken with 
5 lmageQuant™ TL (GE Healthcare Life Sciences) and quantified with Image J. 
6 
7 2.11. TIDE assay 
8 Quantifications of indel frequencies were performed using the TIDE assay as 
9 described previously (Brinkman et al., 2014). Briefly, two days after transfection, 
10 cells were harvested in Lysis buffer CS, 0.5% Tween20, 0.5% NP40, proteinase K 
11 followed by heating at 65°C for 30 min and 95 oc for 10 min (Luo et al., 2011 ). 11JI of 
12 lysate was used as template for PCR with the high fidelity polymerase Platinum® Pfx 
13 DNA Polymerase. PCR products were purified with the NucleoSpin Gel and PCR 
14 Clean Up kit and directly sequenced by Sanger sequencing (Mix2seq, 
15 EurofinGenomics). % indels was quantified by TIDE software (https://tide.nki.nl/). A 
16 p-value cutoft of p<0.001 and indel size range from -10 to + 10 was used for all 
17 analyses, and decomposition windows were optimized for each gRNA according to 
18 TIDE guidelines. For analysis of TIDE data, control values from groups transfected 
19 with a plasmid expressing an empty gRNA backbone were subtracted as these 
20 indicate the non-specific error at each site from the TIDE calculation. 
21 
22 2.12. Statistical analyses 
23 All data are presented as mean ± standard deviation. Student's T-test and one-way 
24 analysis of variance (ANOVA) with Bonferroni correction were used for statistical 
25 analyses of multiple camparisans in the study. All statistical analyses were 
26 conducted using Stata (version 1 0). P values less than 0.05 were considered 
27 statistically significant. 
28 
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1 
2 3. Results 
3 3.1. Fusing SpCas9 to bacterial RecA (rSpCas9) enhances gene knockout and 
4 deletion 
5 The bacterial RecA protein is a single strand DNA (ssDNA) binding protein and ATP-
6 dependent recombinase involved in bacterial homologaus recombination (Chen et 
7 al., 2008). lt has previously been demonstrated that overexpression of RecA 
8 promotes homology-directed gene conversion in mammalian cells (Shcherbakova et 
9 al., 2000). Since RecA is also involved in several HR-related functions ranging from 
10 homology-search to strand-interactions, we hypothesised that it could be an 
11 alternative to mammalian protein domains such as Rad51 for promoting homologaus 
12 recombination. We therefore hypothesized that fusing active SpCas9 to the N-
13 terminus of RecA would yield a fusion protein that promotes homology-directed DSB 
14 repair. 
15 A plasmid expressing a recombinant SpCas9 fused to the N terminus of the human 
16 codon-optimized RecA protein (NP_ 417179.1) was created (Figure 1A). To prevent 
17 potential interference with correct protein folding, a flexible peptidelinker (Giy- Gly-
18 Gly - Gly - Ser, G4S) was used to join SpCas9 and RecA. We first confirmed the 
19 correct size of the SpCas9-RecA fusion protein (hereafter rSpCas9) and its 
20 expression by Western blot. Our results showed that rSpCas9 expression Ieveis 
21 were slightly lower but not significantly different from the wild-type SpCas9 (Figure 
22 1A). We next investigated whether the rSpCas9 fusion endonuclease could still be 
23 programmed by gRNAs to cleave chromosomal DNA in mammalian cells. Five 
24 genomic loci, including two previously validated gRNAs targeting EMX1 and HEK293 
25 site 2 (Tsai et al., 2015), were selected for this analysis (Figure 1 8). Two days after 
26 co-transfecting HEK293T cells with plasmids expressing either SpCas9 or rSpCas9 
27 tagether with a plasmid expressing the gRNA in question, the percentage of indel 
28 mutationswas quantified by the TIDE assay (Brinkman et al., 2014). Surprisingly, we 
29 observed that in four out of five target sites, rSpCas9 was significantly more efficient 
30 at generating indel mutations than SpCas9 (Figure 18. EMX1: 51% increase, 
31 HEK293 site 2: 39%, Chr1: 57%, and Chr18: 93%, p < 0.05 Student's T-test). To 
32 prove that this effect is not cell type-specific, the increased indel mutation rate by 
33 rSpCas9 was further verified in He La and U20S cells (Supplementary Figure 1 ). 
8 
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1 We further confirmed the applicability of rSpcas9 to gene knockout by comparing 
2 gene deletion efficiencies for SpCas9 and rSpCas9 targeting uPA, IGF1 Rand CRP 
3 in HEK293T cells, each with two gRNAs, where a general increase in gene deletion 
4 was observed for rSpCas9 (Figure 1C, 32-84% increase, p < 0.01, Student's T-test). 
5 
6 3.2. rSpCas9 promotes DSB repair by SSA 
7 To investigate whether rSpCas9 enhances DSB repair by SSA, we used our 
8 previously developed C-Check dual fluorescent reporter system (Zhou et al., 2016). 
9 The C-Check system relies on SSA-mediated repair of a DSB at a target site 
10 introduced between two sections of GFP (500 nt homology) in a plasmid 
11 constitutively expressing AsRED. A DSB repaired by SSA will generate a full-length 
12 GFP which can be quantified by flow cytometry (Figure 2A). HEK293T cells were 
13 co-transfected with plasmids expressing either SpCas9 or rSpCas9, and a C-Check 
14 plasmid tagether with one of two gRNAs targeting the C-Check plasmid in question. 
15 The SSA efficiency was quantified by normalizing the number of GFP+ cells to the 
16 number of AsRed+ cells 48 hours after transfection. As shown in Figure 28, C, 
17 rSpCas9 exhibited significantly higher activities in the C-Check assay than SpCas9 
18 (2.1- and 2.5-fold increase, p<0.001 ), indicating an increased preference for SSA-
19 mediated DSB repair. Our results thus suggest that fusion of SpCas9 to E.coli Rec A 
20 facilitates DSB repair by homology-directed SSA in mammalian cells. 
21 
22 3.3. rSpCas9 inhibits DSB repair by homology-directed gene conversion in 
23 traffic light reporter cells 
24 We next investigated the effect of rSpCas9 on DSB repair by homology-directed 
25 gene conversion using a 'traffic light' reporter (TLR) cell line (Chu et al., 2015). 
26 Following generation of a DSB at the TLR locus, repair by homology-directed gene 
27 conversion results in expression of a green fluorescent protein (Venus), whereas a 
28 fraction of the DSB repair events by NHEJ or MMEJ Iead to +2 reading frame 
29 mutations resulting in red fluorescent protein (RFP) expression (Figure 3A). We co-
30 transfected TLR cells with either SpCas9 or rSpCas9, a TLR gRNA targeting the 
31 integrated mutated Venus gene, and a Venus donor plasmid. 72 hours after 
32 transfection, % Venus positive and RFP positive cells were quantified by flow 
33 cytometry. We observed that rSpCas9 exhibited a lower frequency of homology-
9 
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1 directed gene conversion than SpCas9 as quantified by the fraction of Venus 
2 positive cells (Figure 38, C, decreased by 33 %, p < 0.01 ), indicating that the fusion 
3 protein inhibits DSB repair by homology-directed gene conversion. Significantly 
4 higher RFP+ frequencies were observed in the TLR cells expressing rSpCas9 
5 compared to SpCas9 (Figure 38, C, 29% increase, p<0.001 ), which again suggests 
6 a preference for DSB repair by NHEJ/MMEJ when using rSpCas9. Finally, the TLR 
7 system allowed us to compare the preference for DSB repair by homology-directed 
8 gene conversion relative to NHEJ/MMEJ for each of the two proteins by comparing 
9 the ratio of Venus+ to RFP+ cells, where a 48% decrease is seen for rSpCas9 
10 compared to SpCas9 (Figure 3C, p < 0.001 ). This suggests that rSpCas9 can be a 
11 useful tool for gene KO experiments by facilitating error-prone repair over HDR. 
12 To investigate whether rSpCas9 also affects DSB repair by HDR in plasmid-based 
13 systems, we generated a TLR-Iike reporter plasmid (Figure 30). This TLR-Iike 
14 plasmid contains the same mutated Venus coding sequence and TLR gRNA target 
15 site. ln addition, it contains the same CMV-AsRED expression cassette as the C-
16 Check system for normalization. However, using this plasmid-based HDR reporter 
17 system, no significant difference in plasmid-based HDR repair was observed 
18 between SpCas9 and rSpCas9 (Figure 3E, F). 
19 
20 3.4. Fusion of RecA to eSpCas9(1.1) does not affect its mismatch tolerance 
21 A novel, enhanced specificity, SpCas9 variant (eSpCas9(1.1 )) which can only 
22 talerate one mismatch between gRNA and the target locus has recently been 
23 generated (Siaymaker et al., 2016). To investigate whether fusing RecA to 
24 eSpCas9(1.1 ), hereafter referred to as eSpCas9-RecA, can enhance gene knockout 
25 (on-target activity) without interfering with its mismatch tolerance, we transfected 
26 HEK293T cells with a C-Check reporter vector, one of the Cas9 variants 
27 (eSpCas9(1.1.) and eSpCas9-RecA), and one gRNA carrying 0-2 mismatches at 
28 varying positions (Figure 4A). Control cells were transfected with a scrambled gRNA 
29 and one of the Cas9 variants, or transfected with a control plasmid pUC19. 48 hours 
30 after transfection, the relative gene editing efficiencies of the Cas9 proteins were 
31 quantified by flow cytometry by normalizing the number of GFP positive cells to the 
32 number of AsRED positive cells. This assay was repeated in triplicates three times 
33 for each of two target sites (target site 1 and target site 2, Figure 4). We observed 
10 
Page 10 of 23 
1 that eSpCas9-RecA generally showed significantly higher efficiencies in the assay 
2 than eSpCas9(1.1) but the relative increase was less than that observed for rSpCas9 
3 compared to wt SpCas9. Similar increases in targeting efficiency by fusion of RecA 
4 compared to eSpCas9(1.1) were observed for both on-target sites and the off-target 
5 sites with one mismatch. lmportantly, there was no detectable off-target cleavage for 
6 either protein when targeting the G-eheck vectors with gRNAs containing 2 
7 mismatches. 
8 
9 Since we have previously observed a difference between plasmid-based and 
10 genomic assays (Figure 3), we next investigated whether the observed activities of 
11 eSpCas9-RecA are replicated when targeting genomic loci. We first targeted three 
12 genomic loci in HEK293T cells (Chr1, Ch3, and Chr8). Unlike for rSpCas9 and the 
13 reporter system in Figure 48, despite a consistent increase in the frequency of 
14 indels, the difference was not significant for eSpCas9-RecA compared to 
15 eSpCas9(1.1 ). Furthermore, to investigate the mismatch tolerance in the genomic 
16 context, we generated six gRNAs containing 1-2 mismatches to the EMX1 target 
17 site. Using TIDE assay, no difference was observed in either on-target activity or 
18 mismatch tolerance (except OT-1, significantly increased in eSpCas9-RecA) 
19 between eSpCas9(1.1) and eSpCas9-RecA. Both eSpCas9(1.1) and eSpCas9-RecA 
20 had a significantly lower mismatch tolerance than SpCas9 (Figure 4C). Taken 
21 together, our results show that fusing RecA to eSpCas9(1.1) only results in 
22 significantly increased cleavage efficiency (p<0.05) in a plasmid based assay but not 
23 in a genomic context, and that fusing RecA to eSpCas9(1.1) did not affect its 
24 mismatch tolerance. 
25 
26 4. Discussion 
27 ln this study, we have created a recombinant Cas9 protein (SpCas9-RecA; rSpCas9) 
28 with modified preferences for DNA DSB repair in mammalian cells. Previous studies 
29 have found that the majority of indel mutations at target sites resulted from repair of 
30 Cas9/gRNA-induced DBSs by mutation-prone end-joining pathways such as 
31 classical nonhomologaus end-joining (c-NHEJ) and microhomology mediated end-
32 joining (MMEJ) (Canver et al., 2015; Mandal et al., 2014; van Overbeek et al., 2016). 
33 ln this study, we observed that rSpCas9 mediates indel formation 30% more 
11 
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1 efficiently than wild type SpCas9 with a decreased frequency of HDR events, 
2 suggesting that fusion of RecA to SpCas9 enhances DSB-repair by c-NHEJ/MMEJ 
3 at the Cas9/gRNA-induced DSBs relative to error-free repair pathways. ln addition, 
4 we and others have shown that cells also utilized single strand annealing (SSA) 
5 pathways to repair DSBs created by programmable nucleases such as TALENs and 
6 Cas9/gRNA (Kuhar et al., 2014; Yasuda et al., 2016; Zhou et al., 2016). ln this study, 
7 we show that fusing RecA to SpCas9 can also increase the frequency of DSB repair 
8 by SSA. 
9 
10 Furthermore, we have investigated the effect of fusing RecA to SpCas9 on DSB 
11 repair by HDR. Our data suggests that the fusion has a negative effect on DSB 
12 repair by HDR in a genomic context although this effect was not observed in a 
13 plasmid-based HDR assay. Additionally, the effects of fusing Cas9 to RecA were 
14 generally less pronounced for eSpCas9(1.1) than for native SpCas9. The 
15 discrepancy between plasmid-based and genomic results might be due to the copy 
16 number of TLR cassette present in each cell, as weil as other factors such as 
17 chromatin accessibility and modification, interactions of the RecA protein with 
18 chromatin components etc. We also obtained a relatively low basal HDR rate in our 
19 study compared to a study by Liang et al. (Liang et al., 2017). Although similar cells 
20 (HEK293) have been used between Liang et al. and our studies, many other factors 
21 such Cas9 format (RNP in Liang's study, and plasmid in ours), transfection methods 
22 (electroporation in Liang's study, and X-tremeGENE 9 in ours, donor template 
23 (ssDNA in Liang's study, and circular plasmid in ours) etc. might contribute to the 
24 difference in basal HDR rate. Thus, future studies are still required to further 
25 decipher the effect of SpCas9 and recombinant variants such as rSpCas9 on DSB 
26 repair by HDR in mammalian cells. 
27 
28 An early study by Shcherbakova et al. reported that overexpression of E. Coli Rec A 
29 increases homology-directed gene conversion (Shcherbakova et al., 2000). 
30 However, our study reveals that fusion to RecA promotes DSB repair by SSA/MMEJ 
31 rather than homology-directed repair. The discrepancy between the previous study 
32 by Shcherbakova et al. and ours is likely due to: (1) we introduced a DSB whereas 
33 no DSB is introduced in the study by Shcherbakova et al., and (2) the physical 
12 
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1 interaction of Cas9-gRNA with the DSB site may affect repair preferences. Since the 
2 Cas9-gRNA duplexstill remains bound to the DSB site after cutting (Sternberg et al., 
3 2014) and RecA can form RecA-ssDNA filaments following 5' to 3' exonuclease 
4 processing of the broken DNA ends (Chen et al., 2008), RecA may facilitate the 
5 search for homologaus sequences between the two adjacent DNA fragments. This 
6 could also explain our Observation that RecA facilitates SSA/MMEJ-mediated repair 
7 of DSBs generated by CRISPR-Cas9. An increased preference for DSB repair by 
8 SSA was also achieved by overexpression of RecA and SpCas9 (Supplementary 
9 Figure 2), but to a lower extent compared to the SpCas9-RecA fusion. This suggests 
10 that recruitment of RecA to the DSB site is crucial for the enhanced DSB repair by 
11 cNHEJ/MMEJ/SSA. 
12 
13 Recently, it has been shown that transfecting cells with single-stranded non-
14 homologaus DNA oligonucleotides may alter DNA repair outcomes and facilitate 
15 NHEJ (Richardson et al., 2016). lt was hypothesized that cells undergo cycles of 
16 error-free repair and cutting upon treatment with Cas9 until the occurrence of error-
17 prone repair terminates the cycle, and that the inclusion of non-homologaus 
18 oligonucleotides increases the frequency of such error-prone repair. Fusion of RecA 
19 to SpCas9 also increases the frequency of error-prone repair of DSBs but without 
20 the need for co-treatment with other external factors such as non-homologaus DNA 
21 molecules or small chemical inhibitors. This renders rSpCas9 a useful tool for gene 
22 knockout applications. Furthermore, it also suggests that fine-tuning the preference 
23 of DSB repair by using recombinant Cas9 proteins could serve as an alternative 
24 strategy to enhance gene editing by CRISPR/Cas9. 
25 
26 ln summary, we show that fusion of SpCas9 to RecA increases the efficiency of 
27 gene knockout and deletion. As such, we provide a new element to the Cas9 
28 toolbox, but also demonstrate for the first time that mammalian repair pathway 
29 preferences can be altered by fusing active Cas9 to other catalytically active 
30 domains. This is an area with future potential in the ongoing search for methods to 
31 enhance the frequency of homology-directed repair in order to improve the utility of 
32 CRISPR/Cas9 for efficient genome editing in mammalian cells. 
33 
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1 
2 Figure Captions 
3 Figure 1. Fusing SpCas9 to RecA increases the efficiency of gene knockout and deletion 
4 A) Top: Schematic illustration of the SpCas9 and rSpCas9 fusion protein structures; 
5 Middle: Western blot analysis of Cas9 expression (anti FLAG tag, FLAG) and loading 
6 control (anti beta 111 Tubulin, b-Tub); and Bottom: Quantification of SpCas9 and 
7 rSpCas9 expression. Error bars represent one s.d. (n=3, independent transfections). 
8 B) Quantification of indel mutations at five target sites by TIDE assay. The percentage of 
9 lndel mutations at five genomic loci (EMX1, HEK293site2, Chrl, Chr3, and Chr18) was 
10 quantified by TIDE assay for SpCas9 and rSpCas9. Values represent Mean and one 
11 s.d. (n=3, independent transfections). Asterisks represent p < 0.05 (*), and p < 0.01 
12 (**), Student's T-test. 
13 C) Schematic representation of the gRNA binding sites (top), gel electrophoresis 
14 pictures (middle), and quantification of Cas9-mediated deletion of gene segments 
15 (bottom) in uPA (left), /GF1R (middle) and CRP (right) by SpCas9 and rSpCas9. Error 
16 bars represent one s.d. Controls were transfected with the Cas9 expression plasmids 
17 only (n=3, independent transfections). Asterisks represent p < 0.01 (**), Student's T-
18 test. 
19 
20 Figure 2. rSpCas9 promotes the frequency of single strand annealing-mediated repair of 
21 DSBs 
22 A) Schematic illustration of the C-Check dual fluorescent reporter system. 
23 B) Representative flow cytometry plots of untransfected cells, cells transfected with the 
24 C-Check vector only, and cells transfected with the C-Check vector tagether with 
25 either a scrambled gRNA (Ctrl), Tl gRNA or T2 gRNA, and SpCas9 or rSpCas9. 
26 C) Quantification of the percentage of GFP+/AsRED+ cells as mean ± one s.d. (n=3, 
27 independent transfections). Asterisks (***) represents a p value < 0.001 between the 
28 two groups. 
29 
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1 Figure 3. rSpCas9 inhibits the frequency of homology-directed repair of DSBs in TLR cells 
2 A) Schematic illustration of the traffic light reporter system (TLR). 
3 B) Representative flow cytometry plots of TLR cells co-transfected with either SpCas9 
4 (left) or rSpCas9 (right) and either a scrambled gRNA (Ctrl, top) or a TLR gRNA 
5 (bottom). 
6 C) % Venus+ (HDR, left), % RFP+ (NHEJ/MMEJ, middle) and the ratio of% Venus+ to% 
7 RFP+ (right) for TLR cells transfected with either SpCas9 or rSpCas9 and either a 
8 scrambled gRNA or the TLR gRNA. Quantified by FCM, error bars represent one s.d. 
9 (n=3, independent transfections). Asterisks (***) represents a p value < 0.001, 
10 ANOVA. 
11 D) Schematic illustration of the TLR-Iike HDR plasmid reporter system. 
12 E) Representative flow cytometry plots of HEK293T cells co-transfected with TLR gRNA, 
13 either SpCas9 (left) or rSpCas9 (right), and without (top) or with (bottom) TLR donor 
14 plasmid. 
15 F) % of Venus+/AsRED+ cells. Mean and one s.d. (n=3, independent transfections). 
16 Figure 4. Comparison of on-target activity and mismatch tolerance for eSpCas9(1.1} 
17 and eSpCas9-RecA. 
18 A) Percentage of GFP+ out of AsRED positive cells in HEK293T cells transfected with a C-
19 Check reporter vector, one of the Cas9 variants (eSpCas9(1.1) and eSpCas9-RecA), 
20 and one gRNA containing 0-2 mismatches to the target sites (target site 1 or target 
21 site 2) in the C-Check vector or a scrambled gRNA. Negative controls were 
22 transfected with C-Check and a pUC19 plasmid. Error bars represent one SD (n=3, 
23 independent transfections). Asterisks indicate a P value < 0.05, ANOVA. 
24 B) The percentage of lndel mutations by eSpCas9(1.1) and eSpCas9-RecA at three 
25 genomic loci (Chrl, Chr3, and Chr18) in HEK293T cells was quantified by TIDE assay 
26 as mean +- one s.d. (n=3, independent transfections). 
27 C) Percentage of lndel mutations by eSpCas9(1.1) and eSpCas9-RecA at the EMX1 target 
28 site in HEK293T cells was quantified by TIDE assay. ON, OT1, OT2, OT3, OT4, OT5, 
16 
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1 
2 
3 
4 
5 
6 
OT6 represents on-target gRNA and gRNAs with 1-2 mismatches as indicated at the 
bottom. Red boxes indicate mismatch between gRNA and the target site. 
Background value from a group transfected with a control plasmid (pUC19) is 
replotted for comparison. Presented as mean +- one s.d. (n=3, independent 
transfections). 
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1 D) 
2 Supplementary 
3 Figure Sl. Percentage of lndel mutations by SpCas9 and rSpCas9 at the EMX1, Chr1, Chr3, 
4 and Chr18 loci in U20S (A) and EMX1 locus in Hela cells (B), quantified by TIDE assay. 
5 Presented as mean and one s.d. (n=3, independent transfections). Asterisks represents p < 
6 0.05 (*), p < 0.01 (*), Student's T-test. 
7 
8 Figure 52. C-Check quantification of SSA efficiency of SpCas9, SpCas9 in combination with 
9 RecA overexpression, and rSpCas9. The percentage of GFP+ out of the AsRED+ cells was 
10 quantified by flow cytometry. Data represents mean ± one s.d. (n=3, independent 
11 transfections). 
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Figure 2 
 
 
 
Figure 2: rSpCas9 promotes the frequency of single strand annealing-mediated repair of DSBs. 
(A) Schematic illustration of the C-Check dual fluorescent reporter system. (B)Representative 
flow cytometry plots of untransfected cells, cells transfected with the C-Check vector only, 
and cells transfected with the C-Check vector together with either a scrambled gRNA (Ctrl), T1 
gRNA or T2 gRNA, and SpCas9 or rSpCas9. (C) Quantification of the percentage of 
GFP+/AsRED+ cells as mean ± one s.d. (n = 3, independent transfections). Asterisks (***) 
represents a p value < 0.001 between the two groups. 
 
 
 
 
 
 
 
 
 
 
 
 Figure 3 
 
Figure 3: rSpCas9 inhibits the frequency of homology-directed repair of DSBs in TLR cells. (A) Schematic 
illustration of the traffic light reporter system (TLR). (B) Representative flow cytometry plots of TLR 
cells co-transfected with either SpCas9 (left) or rSpCas9 (right) and either a scrambled gRNA (Ctrl, top) 
or a TLR gRNA (bottom). (C) % Venus+ (HDR, left), % RFP+ (NHEJ/MMEJ, middle) and the ratio of % 
Venus+ to % RFP+ (right) for TLR cells transfected with either SpCas9 or rSpCas9 and either a scrambled 
gRNA or the TLR gRNA. Quantified by FCM, error bars represent one s.d. (n = 3, independent 
transfections). Asterisks (***) represents a p value < 0.001, ANOVA. (D) Schematic illustration of the 
TLR-like HDR plasmid reporter system. (E) Representative flow cytometry plots of HEK293T cells co-
transfected with TLR gRNA, either SpCas9 (left) or rSpCas9 (right), and without (top) or with (bottom) 
TLR donor plasmid. (F) % of Venus+/AsRED+ cells. Mean and one s.d. (n = 3, independent transfections). 
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